AROUND CAMPUS
The Center for Sickle Cell Disease at Howard University recognized #WorldSickleCellDay
The Center for Sickle Cell Disease at Howard University recognized World Sickle Cell Day Friday, June 17, with a research symposium that focused on the latest developments in sickle cell science. The program took place at Howard University Interdisciplinary Research Building, with roundtable sessions on the dangers of prescription opioid use among sickle cell patients. “Narcotics are currently our only option for a lot of patients who are trying to manage their daily, chronic pain related to sickle cell disease,” said Dr. Patricia Oneal, clinical director of the Howard University Sickle Cell Disease Center. “These issues deeply affect sickle cell patients.” Participants in the program included: Dr. Anthony Campbell, clinical specialty consultant with the Substance Abuse and Mental Health Services Administration (SAMHSA); Ruth A. Carter, diversion program manager, Drug Enforcement Administration (DEA); Dr. Ann Farrell, director, Division of Hematology Products, Food and Drug Administration; Swee Lay Thein, D.Sc. NHLBI, National Institutes of Health; and Dr. Krupa Sivamurthy, the global
PAGE 4 | Bison Beat Monthly Newsletter | June 2016
http://www.healthcord.com/
medical lead for the Sickle Cell Program at Pfizer. The program also featured Ibrahim Kargbo, a sickle cell disease health advocate who knows the daily challenges of the disease firsthand. Sickle cell disease is an inheritable, genetic disease causing red blood cell disorders, which have been classified as sickle cell anemia, and may lead to death. It is the most common public health problem in African and Asian countries. More than 90,000 to 100,000 people are affected by this disease in the United States. #WorldSickleCellDay is celebrated every year on June 19, to raise public awareness about the disease. It was established by the United Nations General Assembly in 2008.
June 2016 | Bison Beat Monthly Newsletter | PAGE 5